Health Care & Life Sciences » Biotechnology | Arrowhead Pharmaceuticals Corp.

Arrowhead Pharmaceuticals Corp. | Ownership

Companies that own Arrowhead Pharmaceuticals Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
RTW Investments LP
8,299,542
9.43%
5,382,981
7.04%
06/30/2018
OppenheimerFunds, Inc.
7,810,039
8.86%
2,395
0.07%
06/30/2018
BlackRock Fund Advisors
6,591,390
7.49%
3,749,058
0.01%
06/30/2018
First Manhattan Co.
4,530,250
5.15%
0
0.36%
06/30/2018
SSgA Funds Management, Inc.
4,031,856
4.58%
1,478,425
0%
06/30/2018
The Vanguard Group, Inc.
3,763,723
4.28%
350,373
0%
06/30/2018
Adage Capital Management LP
1,503,500
1.71%
0
0.05%
06/30/2018
Acuta Capital Partners LLC
1,030,330
1.17%
-731,876
2.65%
06/30/2018
Northern Trust Investments, Inc.
1,029,693
1.17%
808,176
0%
06/30/2018
Invesco Capital Management LLC
984,963
1.12%
984,963
0.01%
06/30/2018

About Arrowhead Pharmaceuticals

View Profile
Address
225 South Lake Avenue
Pasadena California 91101
United States
Employees -
Website http://www.arrowheadpharma.com
Updated 07/08/2019
Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.